Title:
PHARMACEUTICAL COMPOSITION USED FOR REDUCING LOCALISED FAT AND USE OF PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2017/037594
Kind Code:
A3
Abstract:
Provided is a pharmaceutical composition used for reducing localised fat, said pharmaceutical composition including a plurality of drug-containing micelles formed by a surfactant, and curcumin coated within the drug-containing micelles. The pharmaceutical composition used for reducing localised fat reduces fat at the site of administration, and has advantages such as high stability, high fat tissue bioavailability, low side effects, and sustained release.
More Like This:
| WO/2000/064437 | LONG TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS |
| WO/1994/021241 | NEW USE OF ANTI-ACNE AGENTS |
| WO/1997/019066 | NEW QUINOXALINDIONE DERIVATIVES, THEIR PREPARATION AND USE IN MEDICAMENTS |
Inventors:
LING YU-FANG (CN)
Application Number:
PCT/IB2016/055102
Publication Date:
August 23, 2018
Filing Date:
August 26, 2016
Export Citation:
Assignee:
CALIWAY BIOPHARMACEUTICALS CO LTD (CN)
CALIWAY USA CO LTD (US)
CALIWAY USA CO LTD (US)
International Classes:
A61K31/00; A61K47/00
Domestic Patent References:
| WO2014138426A2 | 2014-09-12 | |||
| WO2017037593A2 | 2017-03-09 |
Foreign References:
| US20010021703A1 | 2001-09-13 | |||
| US20050267221A1 | 2005-12-01 | |||
| US20110151103A1 | 2011-06-23 |
Other References:
KANG ET AL.: "Curcumin decreases oleic acid-induced lipid accumulation via AMPK phosphorylation in hepatocarcinoma cells", EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol. 17, no. 19, October 2013 (2013-10-01), pages 2578 - 2586, XP055536312
Attorney, Agent or Firm:
LUNG TIN INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF: